亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Comparative Effectiveness and Safety of Ticagrelor Versus Clopidogrel for Elderly Chinese Patients Undergoing Percutaneous Coronary Intervention: A Single-Center Retrospective Cohort Study

医学 替卡格雷 氯吡格雷 经皮冠状动脉介入治疗 内科学 阿司匹林 冠状动脉疾病 心肌梗塞 队列 回顾性队列研究 心脏病学
作者
Suining Xu,Ying Liu,Yan Chen,Haoran Gao,Zhen Tan,Qingyi Wang,Yang Liu,Boda Zhu,Tao Feng,Qiong Wang,Shen Zhao,Li Yang,Yamin Zhang,Ziwei Wang,Ping Han,Yuhao Chen,Anji Zhang,Chengxiang Li,Kun Lian
出处
期刊:Drugs & Aging [Adis, Springer Healthcare]
卷期号:39 (9): 695-703 被引量:1
标识
DOI:10.1007/s40266-022-00971-w
摘要

BackgroundTaking ischemic and bleeding risks into consideration, insufficient data exist on dual antiplatelet therapy after percutaneous coronary intervention in elderly Chinese patients with coronary artery disease.ObjectiveWe aimed to investigate the effectiveness and safety of ticagrelor in comparison with clopidogrel on a background of aspirin for elderly Chinese patients with coronary artery disease 12 months after percutaneous coronary intervention.MethodsA single-center retrospective cohort study was conducted. Selected from patients with coronary artery disease aged ≥ 75 years from January 2010 to July 2019, 908 eligible subjects receiving dual antiplatelet therapy after percutaneous coronary intervention for up to 12 months were consecutively enrolled in the study. The included patients received ticagrelor in combination with aspirin (n = 264) or clopidogrel in combination with aspirin (n = 644). Effectiveness endpoints were evaluated by the major adverse cardiovascular events, encompassing all-cause death, non-fatal myocardial infarction, and clinically driven revascularization. The safety endpoints were recorded as the incidence of Bleeding Academic Research Consortium bleeding.ResultsThe patients who were treated with ticagrelor were slightly younger than those who were treated with clopidogrel (79.1 ± 3.7 vs 80.7 ± 4.5 years, p < 0.01). The ticagrelor cohort contained a higher percentage of patients undergoing a prior percutaneous coronary intervention (37.9% vs 24.5%, p < 0.01), and a lower percentage of smokers (19.3% vs 27.2%, p < 0.05), compared with the clopidogrel cohort. The levels of glucose, total cholesterol, and low-density lipoprotein-cholesterol in the ticagrelor group were higher while the level of triglycerides and high-density lipoprotein-cholesterol were lower (p < 0.05) than those in the clopidogrel group. Left main percutaneous coronary intervention was performed more frequently among the ticagrelor-treated patients (23.5% vs 9.3%, p < 0.01), while patients in the clopidogrel group underwent more left circumflex percutaneous coronary intervention (34.3% vs 23.1%, p < 0.01). We found that ticagrelor was associated with a lower incidence of major adverse cardiovascular events than clopidogrel using the inverse probability of treatment weighting model (odds ratio, 0.493; 95% confidence interval 0.356–0.684). There was no difference in terms of the risk of Bleeding Academic Research Consortium bleeding between the two groups (p > 0.05).ConclusionsTicagrelor was associated with a lower incidence of major adverse cardiovascular events than clopidogrel at 12 months in elderly Chinese patients with coronary artery disease, without a significant increase of Bleeding Academic Research Consortium bleeding events.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
2秒前
8秒前
星辰大海的应助被现实的如之采纳,获得10
16秒前
风中的晓兰完成签到,获得积分10
22秒前
温暖的岂愈完成签到,获得积分10
23秒前
善良的觅荷完成签到,获得积分10
53秒前
LL完成签到 ,获得积分10
1分钟前
1分钟前
null的应助被科研通管家采纳,获得10
1分钟前
null的应助被科研通管家采纳,获得10
1分钟前
null的应助被科研通管家采纳,获得10
1分钟前
秋风的应助被科研通管家采纳,获得10
1分钟前
1分钟前
1分钟前
jb4652完成签到,获得积分10
1分钟前
1分钟前
无限寒珊完成签到,获得积分10
1分钟前
落润晓发布了新的文献求助10
1分钟前
欣喜的凡霜完成签到,获得积分10
1分钟前
Rick完成签到,获得积分10
1分钟前
tszjw168完成签到 ,获得积分10
1分钟前
拼搏淇完成签到,获得积分10
2分钟前
Lucas的应助被taka采纳,获得10
2分钟前
执着忆寒完成签到,获得积分10
2分钟前
嘻嘻哈哈的应助被活力棉花糖采纳,获得10
2分钟前
2分钟前
taka发布了新的文献求助10
2分钟前
科研通AI6.4的应助被晚星采纳,获得10
2分钟前
2分钟前
Rick发布了新的文献求助10
2分钟前
踏实的白卉完成签到,获得积分10
2分钟前
跳跃的冰安完成签到,获得积分10
3分钟前
null的应助被科研通管家采纳,获得10
3分钟前
3分钟前
3分钟前
3分钟前
晚星发布了新的文献求助10
3分钟前
3分钟前
美满的幼旋完成签到,获得积分10
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158751
求助须知:如何正确求助?哪些是违规求助? 9554476
关于积分的说明 21719285
捐赠科研通 7748357
什么是DOI,文献DOI怎么找? 3427080
关于科研通互助平台的介绍 2551971
邀请新用户注册赠送积分活动 2471339